Register Login
Register to leave comments
  • News bot May 6, 2026, 1:54 p.m.

    📋 ACTUATE THERAPEUTICS, INC. (ACTU) - Clinical Trial Update

    Filing Date: 2026-05-06

    Accepted: 2026-05-06 09:45:08

    Event Type: Clinical Trial Update

    Event Details:

    ACTUATE THERAPEUTICS, INC. (ACTU) Announces Clinical Trial Update ACTUATE THERAPEUTICS, INC. (ACTU) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: outcomes, expertise
    • Diseases/Conditions: advancing our programs toward key goals, oncology drug development
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: Independent

    🔬 Clinical Development Pipeline (ACTUATE THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Chemotherapy Drug Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Standard Lancing Device Device Approved Pain From Heel Sticks ClinicalTrials.gov
    BabyGentleStick Other Approved Pain From Heel Sticks ClinicalTrials.gov
    9-ING-41 Other Phase PHASE2 Sarcoma ClinicalTrials.gov
    Docetaxel Other Phase PHASE2 Sarcoma ClinicalTrials.gov
    Gemcitabine Other Phase PHASE2 Sarcoma ClinicalTrials.gov
    BabyGentleStick™ OFF Other Approved Lack of Adverse Events ClinicalTrials.gov
    BabyGentleStick™ ON Other Approved Lack of Adverse Events ClinicalTrials.gov
    Ruxolitinib Other Phase PHASE2 Myelofibrosis ClinicalTrials.gov
    TubeClear® intervention Other Approved Enteral Nutrition ClinicalTrials.gov
    Carboplatin Other Phase PHASE2 Salivary Gland Cancer ClinicalTrials.gov
    Abraxane Other Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Retifanlimab Other Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Topotecan Other Phase PHASE1 Refractory Cancer ClinicalTrials.gov
    Cyclophosphamide Other Phase PHASE1 Refractory Cancer ClinicalTrials.gov
    Temozolomide Other Phase PHASE1 Refractory Cancer ClinicalTrials.gov
    Irinotecan Other Phase PHASE1 Refractory Cancer ClinicalTrials.gov
    Losartan Other Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    FOLFIRNINOX Other Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Gemcitabine - 28 day cycle Other Phase PHASE2 Cancer ClinicalTrials.gov
    Paclitaxel. Other Phase PHASE2 Cancer ClinicalTrials.gov
    Nab paclitaxel. Other Phase PHASE2 Cancer ClinicalTrials.gov
    Carboplatin. Other Phase PHASE2 Cancer ClinicalTrials.gov
    Lomustine Other Phase PHASE2 Cancer ClinicalTrials.gov
    Doxorubicin. Other Phase PHASE2 Cancer ClinicalTrials.gov
    Gemcitabine - 21 day cycle Other Phase PHASE2 Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ACTUATE THERAPEUTICS, INC.
    • Ticker Symbol: ACTU

Search

News categories